Pages that link to "Q35182214"

The following pages link to Niacin and cholesterol: role in cardiovascular disease (review). (Q35182214):

Displaying 32 items.

• Flushing out the role of GPR109A (HM74A) in the clinical efficacy of nicotinic acid (Q24536167) (← links)
• beta-Arrestin1 mediates nicotinic acid-induced flushing, but not its antilipolytic effect, in mice (Q24654027) (← links)
• The Role of Vitamins in the Pathogenesis of Non-alcoholic Fatty Liver Disease (Q26752762) (← links)
• The genetics and screening of familial hypercholesterolaemia (Q26753081) (← links)
• Niacin in pharmacological doses alters microRNA expression in skeletal muscle of obese Zucker rats (Q33646129) (← links)
• Hepatoprotective, Antihyperlipidemic, and Anti-inflammatory Activity of Moringa oleifera in Diabetic-induced Damage in Male Wistar Rats (Q33655699) (← links)
• Combination of niacin extended-release and simvastatin results in a less atherogenic lipid profile than atorvastatin monotherapy (Q34417470) (← links)
• Pharmacological doses of niacin stimulate the expression of genes involved in carnitine uptake and biosynthesis and improve the carnitine status of obese Zucker rats (Q35204914) (← links)
• New lipid-lowering agents (Q35602647) (← links)
• Association of Early Atherosclerosis with Vascular Wall Shear Stress in Hypercholesterolemic Zebrafish (Q35839671) (← links)
• Proteomic analysis of plasma after branched chain enriched mixture supplementation in mice (Q36744297) (← links)
• High density lipoprotein cholesterol: an evolving target of therapy in the management of cardiovascular disease (Q36766976) (← links)
• Targeting multiple dyslipidemias with fixed combinations--focus on extended release niacin and simvastatin (Q37019920) (← links)
• Thinking beyond low-density lipoprotein cholesterol: strategies to further reduce cardiovascular risk (Q37367666) (← links)
• Independent and combined effects of aerobic exercise and pharmacological strategies on serum triglyceride concentrations: a qualitative review (Q37667487) (← links)
• New evidence for nicotinic acid treatment to reduce atherosclerosis (Q37799365) (← links)
• Emerging options in the treatment of dyslipidemias: a bright future? (Q37842462) (← links)
• The role of B vitamins in the management of heart failure (Q38003836) (← links)
• Update on lipoprotein(a) as a cardiovascular risk factor and mediator. (Q38132701) (← links)
• A current approach to statin intolerance (Q38204184) (← links)
• Interaction of ibuprofen and other structurally related NSAIDs with the sodium-coupled monocarboxylate transporter SMCT1 (SLC5A8). (Q40275023) (← links)
• Clinical utility of extended-release niacin: update and summary (Q40393690) (← links)
• Sodium-coupled and electrogenic transport of B-complex vitamin nicotinic acid by slc5a8, a member of the Na/glucose co-transporter gene family (Q42268126) (← links)
• Combined treatment with Dif1stat and diet reduce plasma lipid indicators of moderate hypercholesterolemia more effectively than diet alone: a randomized trial in parallel groups (Q43242953) (← links)
• Identification of tartary buckwheat tea aroma compounds with gas chromatography-mass spectrometry (Q45071267) (← links)
• CAT-2003: A novel sterol regulatory element-binding protein inhibitor that reduces steatohepatitis, plasma lipids, and atherosclerosis in apolipoprotein E*3-Leiden mice. (Q51754950) (← links)
• The effect of combined treatment with niacin and chromium (III) chloride on the different tissues of hyperlipemic rats. (Q51789318) (← links)
• Lipid fraction quality of milk produced by Minhota (Portuguese autochthonous breed) compared to Holstein Friesian cow's (Q58778318) (← links)
• Fatty acid composition and conjugated linoleic acid content in different carcass parts of Dağlıç lambs (Q59100922) (← links)
• Impact of lipid-lowering therapy on glycemic control and the risk for new-onset diabetes mellitus (Q59804280) (← links)
• Mechanisms of drug combinations: interaction and network perspectives (Q83265745) (← links)
• Regulation of rat hepatic α-amino-β-carboxymuconate-ε-semialdehyde decarboxylase, a key enzyme in the tryptophan- NAD pathway, by dietary cholesterol and sterol regulatory element-binding protein-2 (Q85697205) (← links)